Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human Microbiome
Posted: Mon Nov 06, 2017 4:05 pm
International Clostridium Difficile Support Group
http://cdiffdiscuss.org/PHPBB3/